REGN727 (SAR236553)

alirocumab · Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for REGN727 (SAR236553), covering 2015-01-27 to 2015-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Ascending Dose Study of the Safety and Tolerability of REGN727 (SAR236553) in Healthy Volunteers [Phase 1]